Owner ExonHit S.A.

Convention FR 20 August 2010 10 3 761 324

IR Number 1063526

Filing Date 24 August 2010

Class 1 Chemical preparations and compositions, namely nucleic acids attached to a solid medium intended for industry and science; fissile chemical elements; chemicals for analyses, other than for medical or veterinary purposes; biological preparations, other than for medical or veterinary purposes, namely biological preparations enabling the quantification of nucleic acid content; chemicals for scientific use, other than for medical or veterinary purposes; chemical preparations or reagents for laboratory analyses, other than for medical or veterinary purposes; preparations for diagnosis, other than for medical or veterinary purposes

Class 5 Pharmaceutical preparations for treating neurodegenerative diseases, particularly Alzheimer's disease; tests, namely tests based on blood biomarkers enabling the identification of patients suffering from Alzheimer's disease or at risk of developing the disease and enabling the identification of patients responding to specific treatments; acidic biological preparations and products for pharmaceutical purposes, namely pharmaceutical preparations for diagnosing Alzheimer's disease; capsules for diagnostic tests and medicines; chemico-pharmaceutical preparations for diagnosing, preventing and treating Alzheimer's disease; biopharmaceutical preparations for diagnosing, preventing and treating Alzheimer's disease; chemicals for medical, pharmaceutical or veterinary purposes, especially for diagnosing neurodegenerative diseases, especially Alzheimer's disease; products for medical and clinical diagnosis, namely probes and kits for medical and clinical diagnosis, comprising nucleic acid banks, nucleic acids on DNA chips; DNA libraries, particularly for decoding the genes affected by Alzheimer's disease or revealing the transcriptomic signature of patients suffering from Alzheimer's disease; DNA chips containing DNA for decoding the genes affected by Alzheimer's disease or revealing the transcriptomic signature of patients suffering from Alzheimer's disease; chips, namely DNA chips, with the aim of making visible and analyzing gene expression in the fields of human medicine, pharmacology and veterinary sciences; enzymes or enzyme preparations for medical or veterinary purposes, namely enzyme stabilizers, enzyme substrates used as ingredients in medicines for Alzheimer's disease; reagents (contained in kits for taking blood samples) required for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions

Class 10 Surgical, medical, dental and veterinary apparatus and instruments, particularly for identifying, assessing the seriousness of, assessing prognoses of, measuring the progression of and measuring the conversion of diseases; medical devices using DNA chips for analyzing blood; apparatus for analyzing blood; apparatus using DNA chips for diagnosis, for medical purposes, namely DNA chips for diagnosing Alzheimer's disease, namely materials for taking blood (contained in kits for taking blood samples) required for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions; spoons for medicines; containers for the application of medicines; probes for medical purposes; syringes for medical purposes; galvanic therapeutic appliances, particularly for diagnosing neurodegenerative diseases, especially Alzheimer's disease

Class 42 Research and development, for others, of pharmaceutical molecules or biological markers and medicines for diagnosing and treating neurodegenerative diseases; chemical analyses; chemical research; chemical services, namely analysis of RNA genes, tissues, and blood samples; biotechnological project studies, particularly to enable the identification of people suffering from Alzheimer's disease and to measure the seriousness, prognoses, progression and conversion of the disease and to determine how patients respond to treatments; research and development of new products for others; biological research; biotechnological research; technical research in the field of biotechnology; biotechnological analysis services; laboratory analyses, namely quantification of nucleic acid content

Class 44 Medical services; veterinary services; medical assistance; consulting in the fields of biotechnology and pharmacy, namely to assist in the selection of Alzheimer's sufferers for clinical trials and to offer personalized treatments; hospitals; pharmaceutical industry and pharmacist (preparing prescriptions) services, namely geriatric and neurological services in order to facilitate diagnoses and care; health care; telemedicine services